0.4031
price up icon0.47%   0.0019
after-market After Hours: .40 -0.0031 -0.77%
loading

Traws Pharma Inc Stock (TRAW) Forecast

The Traws Pharma Inc (TRAW) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.4627, representing a +14.78% increase from the current price of $0.4031. The highest analyst price target is $0.8919, and the lowest is $0.0335.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TRAW Price Target
Average 3.9172 (+871.76% Upside)
loading

Is Traws Pharma Inc (TRAW) A Buy Now?

Oscillators
Name Value Action
RSI(14) 30.98 Neutral
STOCH(9,6) 4.7259 Buy
STOCHRSI(14) 1.4161 Buy
MACD(12,26) -0.038 Sell
ADX(14) 19.49 Neutral
William %R -95.88 Buy
CCI(14) -107.91 Sell
Buy: 3 Sell: 2 Neutral: 2
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
0.4659
Sell
0.4538
Sell
MA20
0.506
Sell
0.4884
Sell
MA50
0.5342
Sell
0.5603
Sell
MA100
0.7091
Sell
0.7486
Sell
MA200
1.2214
Sell
1.0632
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, TRAW could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on TRAW, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 30.98 indicates that TRAW is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 4.7259 indicates that TRAW is oversold. This indicates that TRAW price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 1.4161 indicates that TRAW is oversold. This suggests that TRAW price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 19.49 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -107.91 indicates that TRAW is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term TRAW price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Traws Pharma Inc financial reports and earnings history, Traws Pharma Inc (TRAW) stock could reach $18.50 by 2030, $25.48 by 2040 and $107.82 by 2050. See the projected annual prices until 2050 of the Traws Pharma Inc stock below:

  • Traws Pharma Inc (TRAW) is expected to reach an average price of $3.5137 in 2035, with a high prediction of $4.8221 and a low estimate of $3.5313. This indicates an $771.67% rise from the last recorded price of $0.4031.
  • Traws Pharma Inc (TRAW) stock is projected to chart a bullish course in 2040, with an average price target of $22.79, representing an $5,555% surge from its current level. The forecast ranges from a conservative $23.04 to a sky-high $25.48.
  • Our analysts predict Traws Pharma Inc (TRAW) to jump 14,341% by 2045, soaring from $58.34 to an average price of $58.21, potentially reaching $61.00. While $58.34 is the low estimate, the potential upside is significant.
  • Traws Pharma Inc (TRAW) stock is expected to climb by 2050, reaching an average of $104.02, a $25,704% jump from its current level. However, a wide range of estimates exists, with high and low targets of $107.82 and $104.34, respectively, highlighting the market's uncertainty.

Traws Pharma Inc Stock (TRAW) Year by Year Forecast

Traws Pharma Inc Stock (TRAW) Price Forecast for 2026

The predicted value for Traws Pharma Inc (TRAW) in 2026 is set at an average of $1.6318. Estimates vary from a peak of $3.23 to a trough of $0.0335, indicating an +304.80% surge from the present price of $0.4031.
Month Average Low High Change from today's price
November, 2026 $0.18 $0.0335 $0.8919 -55.35%
December, 2026 $3.6383 $0.8718 $2.3782 +802.57%

Traws Pharma Inc Stock (TRAW) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Traws Pharma Inc (TRAW) is $5.3712, with a high forecast of $8.2858 and a low forecast of $2.4567. This indicates an +1,232% increase from the last price of $0.4031.
Month Average Low High Change from today's price
January, 2027 $4.0391 $4.6547 $4.9376 +902.00%
February, 2027 $5.5701 $4.7205 $4.8949 +1,282%
March, 2027 $5.1096 $5.2081 $4.6521 +1,168%
April, 2027 $7.8833 $7.7385 $7.5779 +1,856%
May, 2027 $7.8843 $7.9551 $7.8008 +1,856%
June, 2027 $7.8609 $7.808 $7.6909 +1,850%
July, 2027 $1.4133 $2.4567 $7.4333 +250.61%
August, 2027 $4.7339 $3.6309 $4.4039 +1,074%
September, 2027 $6.5497 $4.3918 $4.3197 +1,525%
October, 2027 $7.7555 $7.8612 $7.7542 +1,824%
November, 2027 $8.0728 $8.1128 $8.1148 +1,903%
December, 2027 $8.2885 $8.3171 $8.2858 +1,956%

Traws Pharma Inc Stock (TRAW) Price Forecast for 2028

In 2028, Traws Pharma Inc (TRAW) is projected to reach an average price of $5.1712, with a high projection of $7.97 and a low estimate of $2.3724. This indicates an +1,183% rise from the last price of $0.4031.
Month Average Low High Change from today's price
January, 2028 $7.3858 $7.4758 $7.97 +1,732%
February, 2028 $7.1916 $7.2116 $7.2563 +1,684%
March, 2028 $6.6674 $6.7074 $6.923 +1,554%
April, 2028 $6.3632 $6.4132 $6.5688 +1,479%
May, 2028 $5.3804 $5.4092 $6.2246 +1,235%
June, 2028 $3.9362 $4.2362 $5.1518 +876.48%
July, 2028 $3.9434 $4.1091 $3.8534 +878.27%
August, 2028 $4.5442 $3.8278 $3.4249 +1,027%
September, 2028 $4.045 $4.125 $4.3921 +903.47%
October, 2028 $2.9222 $3.0222 $3.1465 +624.94%
November, 2028 $2.408 $2.873 $2.9351 +497.38%
December, 2028 $2.3338 $2.3724 $2.1838 +478.97%

Traws Pharma Inc Stock (TRAW) Price Forecast for 2029

The 2029 price forecast for Traws Pharma Inc Stock (TRAW) is $9.9916 on average, with a high prediction of $19.88 and a low estimate of $0.108. This represents an +2,379% increase from the previous price of $0.4031.
Month Average Low High Change from today's price
January, 2029 $1.9411 $2.0311 $2.2182 +381.53%
February, 2029 $1.5368 $1.5468 $1.2769 +281.26%
March, 2029 $1.7356 $1.5583 $1.6176 +330.57%
April, 2029 $1.5318 $1.4864 $1.5602 +280.00%
May, 2029 $1.0557 $1.0757 $1.3759 +161.89%
June, 2029 $0.5872 $0.6284 $0.8521 +45.66%
July, 2029 $0.1635 $0.175 $0.4489 -59.44%
August, 2029 $15.76 $0.108 $15.55 +3,811%
September, 2029 $15.88 $15.84 $15.13 +3,839%
October, 2029 $19.14 $16.24 $18.31 +4,649%
November, 2029 $18.69 $19.44 $19.88 +4,537%
December, 2029 $19.11 $19.52 $19.29 +4,640%

Traws Pharma Inc Stock (TRAW) Price Forecast for 2030

Traws Pharma Inc Stock (TRAW) is expected to reach an average price of $17.73 in 2030, with a high forecast of $21.00 and a low forecast of $14.46. This signifies an +4,299% surge from the last price of $0.4031.
Month Average Low High Change from today's price
January, 2030 $20.38 $19.17 $18.50 +4,956%
February, 2030 $21.40 $21.36 $21.00 +5,209%
March, 2030 $20.76 $20.83 $21.00 +5,050%
April, 2030 $19.89 $20.06 $20.13 +4,835%
May, 2030 $14.92 $14.46 $19.26 +3,600%
June, 2030 $16.20 $15.31 $15.87 +3,918%
July, 2030 $18.53 $15.64 $17.34 +4,497%
August, 2030 $18.57 $18.61 $18.46 +4,508%
September, 2030 $18.34 $18.17 $18.28 +4,449%
October, 2030 $17.83 $17.98 $18.12 +4,323%
November, 2030 $16.46 $16.55 $17.27 +3,984%
December, 2030 $15.55 $15.68 $16.16 +3,757%
$7.50
price up icon 1.35%
$10.27
price up icon 0.39%
$5.74
price up icon 5.03%
$18.93
price up icon 5.17%
$10.91
price up icon 6.03%
WVE WVE
$3.19
price up icon 3.24%
Cap:     |  Volume (24h):